Best in Biotech 14 Mar 2024
7 oncolytic virus companies you should know about
Find out more about 7 oncolytic virus companies advancing their drug candidates through clinical trials to help cancer patients.
- Latest Posts
In Depth 13 Mar 2024
From LSD to healing minds: Where are we standing in psychedelic drug development?
Delve into the growing sector of psychedelic drug development to find out where we are coming from, and where we are standing in the field.
Best in Biotech 12 Mar 2024
The twelve hottest biotech companies in the Boston area
Explore Boston’s vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
In Depth 11 Mar 2024
Biotech bankruptcies: what to expect in 2024 following a record year?
2023 broke the record for the highest number of biotech bankruptcies in a decade. Can biotechs mitigate the risk in 2024?
Best in Biotech 8 Mar 2024
Eight biotechnology universities in Germany cultivating future leaders
Explore Germany’s top biotechnology universities! Uncover where tomorrow’s leaders are trained, bridging science with market success.
Podcast 8 Mar 2024
AI immune system mapping to boost drug discovery
Immunai is using artificial intelligence to map the immune system. The company hopes this will lead to better and faster drug discovery.
ADVERTISEMENT
ADVERTISEMENT
In Depth 7 Mar 2024
Can AbbVie’s legacy live beyond its once best-selling drug Humira?
The sales of AbbVie’s Humira, once a best-seller, have dropped. Now, with a new CEO announced, things are about to change for the company.
Best in Biotech 7 Mar 2024
6 biotech companies tackling antibiotic resistance
Discover six antibiotic companies developing novel therapies in an attempt to overcome the global issue of antibiotic resistance.
In Depth 6 Mar 2024
The biggest private biotech investments in February 2024
The companies BioAge Labs, Latigo Biotherapeutics, and Neurona Therapeutics bagged the biggest private biotech investments in February 2024.
Best in Biotech 5 Mar 2024
Fourteen biotech companies with market caps exceeding $100 billion
Discover the biotech leaders with a market capitalization exceeding $100 billion, driving innovation and shaping tomorrow’s breakthroughs.
In Depth 4 Mar 2024
ALS: how close are we to a cure?
Let us take a look at how the hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past few years.
Expert Advice 1 Mar 2024
Tips on how to write a compelling biotech resume
Discover expert advice from recruiters on crafting a standout biotech resume that grabs employers’ attention and lands you interviews.
ADVERTISEMENT
